109 results
Page 3 of 6
424B5
q2vlmnvim80fqe
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
7gve8dibk70 ix
16 Feb 21
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
8:10am
8-K
EX-99.1
b0qzjg
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
424B5
g1eanph8c0usf
11 Feb 21
Prospectus supplement for primary offering
5:28pm
424B2
hrax6f q8
2 Oct 20
Prospectus for primary offering
4:16pm
8-K
EX-99.1
4ayji2bwti922p4
10 Aug 20
Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
5:00pm
8-K
EX-99.1
va9ftm6on5y0yajpgm
29 Jul 20
Diffusion Pharmaceuticals Receives FDA Guidance for International Phase 1b/2b COVID-19 Clinical Program with TSC
8:14am
8-K
EX-99.1
zcl qrmxjb
7 Jul 20
Phase 1b dosing expected to begin this month
4:38pm
8-K
EX-99.1
us719mzfw5byp
12 Jun 20
Dosing expected to begin in Q2 2020 with first data in Q3 2020
12:18pm
424B3
5rshph sqsrivf5y
8 Jun 20
Prospectus supplement
4:48pm
8-K
EX-99.1
62ncz3qt
26 May 20
Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program
4:45pm
8-K
EX-99.1
v4ivoc
20 May 20
Other Events
5:27pm